NFE2L2 and cancer: Inhibition of NFE2L2 can sensitize cancer cells to ferroptosis-inducing agents, thereby enhancing the efficacy of chemotherapy, radiotherapy, and targeted therapies that rely on oxidative stress to eliminate tumor cells[132-137].